SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Appen Limited (APPEF) , forward earnings yield 0.77%. PEG 0.99 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 129.9
- PEG Ratio 0.99 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 39/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — APPEF
Valuation Multiples
P/E (TTM)0.0
Forward P/E129.9
PEG Ratio0.99
Forward PEG0.99
P/B Ratio0.00
P/S Ratio1.11
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.09
Forward EPS (Est.)$0.01
Book Value / Share$0.00
Revenue / Share$0.90
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield0.77%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.07 |
$79.9M |
$7.55M |
9.5% |
| 2017 |
$0.11 |
$129.91M |
$11.14M |
8.6% |
| 2018 |
$0.26 |
$256.55M |
$29.39M |
11.5% |
| 2019 |
$0.24 |
$374.89M |
$29.13M |
7.8% |
| 2020 |
$0.31 |
$460.84M |
$38.84M |
8.4% |
| 2021 |
$0.23 |
$447.15M |
$28.52M |
6.4% |
| 2022 |
$-1.94 |
$388.13M |
$-239.07M |
-61.6% |
| 2023 |
$-0.83 |
$273.01M |
$-118.08M |
-43.3% |
| 2024 |
$-0.09 |
$234.29M |
$-20.01M |
-8.5% |
| 2025 |
$-0.09 |
$238.8M |
$-22.58M |
-9.5% |
